摘要
Objective： To analyze the clinical characteristics and medical treatment of hospitalized patients with chronic heartfailure, and provide medication for the patients. Methods： According to medical records of inpatients, demographicinformation, etiology, clinical features and treatment information were collected. Results： A total of 610 cases withheart failure from our hospital between July 2010 and June 2016 were analyzed. The average age of all the patientswas 63. Males accounted for 50.49%. There were 82.7% patients with NYHA functional classification at III-IV.31.3% patients with coronary artery disease, 28.4% with rheumatic heart diseases and 21.8% with expansion ofheart disease. 27.4 percent of the patients with the left ventricular ejection fraction lower than 40%. There were78.9% patients received aldosterone antagonist treatment, 63.4% received ACEI/ARB, 62.1% received digoxin,59.8% received beta blockers, and 75.4% patients received decoction, and 80.8% received Chinese patent medicine.Conclusion： The study has shown that high utilization of traditional Chinese medicine is to highlight theadvantages of the combination of traditional Chinese and western medicine in the treatment of heart failure. Theusage of spironolactone, ACEI/ARB, beta blockers in our hospital was lower than the ratio reported, higher thanthat of the national average. However, the use of diureticis is lower than that of national average, which may relateto the use of damp-clearing herbs. Clinicians should pay attention to the high utilization rate of digoxin. Patientswith the left ventricular ejection fraction 〉 50% accounted for 61.1%, which required more attention should be paidto the diagnosis and treatment of patients with heart failure of the ejection fraction remains.
目的：分析慢性心力衰竭住院患者临床特点和药物治疗情况,总结慢性心力衰竭临床特点,为患者的药物治疗提供依据.方法：根据住院心衰患者病例资料,收集其人口学信息、心衰病因及临床特点和治疗情况.结果：对河南中医药大学第一附属医院2010年7月至2016年6月,共610例心衰患者进行数据分析,患者平均年龄为63.03岁,男性占50.49%,大部分患者为美国纽约心脏协会心功能分级Ⅲ～Ⅳ级,占82.7%.心衰患者中冠心病占31.3%、风心病占28.4%、扩心病占21.8%,左室射血分数〈40%的患者占27.4%.住院期间醛固酮受体拮抗剂的应用率为78.9%,ACEI/ARB为63.4%,地高辛为62.1%,β受体阻滞剂为59.8%,中药汤药为75.4%,中成药为80.8%.结论：中成药、汤药使用比率较高,充分突出中西医结合特色治疗心衰病的优势;在螺内酯、ACEI/ARB（血管紧张素转换酶抑制剂/血管紧张素Ⅱ受体拮抗剂）、β受体阻滞剂等药物运用低于指南水平,高于国内平均水平,其中利尿剂使用低于国内平均水平,这可能与利水渗湿药的运用关系密切;地高辛使用率较高,提示临床医师注意;左室射血分数≥50%的患者占61.1%,这要求我们更加重视射血分数保留心衰患者的诊断及治疗.
